Watson Pharma to buy Arrow Group for $1.75 billion
June 17, 2009 at 10:06 AM EDT
Watson Pharmaceuticals agrees to acquire rival generic drugmaker Arrow Group for $1.75 billion in stock and cash, as part of an effort to expand its global reach and enter the nascent market for generic biologics.
